IL193094A - Appalidine and other drugs used in the manufacture of a cancer treatment drug when the combination of the two gives a synergistic result - Google Patents
Appalidine and other drugs used in the manufacture of a cancer treatment drug when the combination of the two gives a synergistic resultInfo
- Publication number
- IL193094A IL193094A IL193094A IL19309408A IL193094A IL 193094 A IL193094 A IL 193094A IL 193094 A IL193094 A IL 193094A IL 19309408 A IL19309408 A IL 19309408A IL 193094 A IL193094 A IL 193094A
- Authority
- IL
- Israel
- Prior art keywords
- aplidine
- medicament
- cancer
- manufacture
- treatment
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K45/00—Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
- A61K45/06—Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
- A61K38/04—Peptides having up to 20 amino acids in a fully defined sequence; Derivatives thereof
- A61K38/15—Depsipeptides; Derivatives thereof
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
- A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
- A61K38/19—Cytokines; Lymphokines; Interferons
- A61K38/20—Interleukins [IL]
- A61K38/2013—IL-2
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
- A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
- A61K38/19—Cytokines; Lymphokines; Interferons
- A61K38/21—Interferons [IFN]
- A61K38/212—IFN-alpha
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P11/00—Drugs for disorders of the respiratory system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P13/00—Drugs for disorders of the urinary system
- A61P13/08—Drugs for disorders of the urinary system of the prostate
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P13/00—Drugs for disorders of the urinary system
- A61P13/12—Drugs for disorders of the urinary system of the kidneys
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P17/00—Drugs for dermatological disorders
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
- A61P35/02—Antineoplastic agents specific for leukemia
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P7/00—Drugs for disorders of the blood or the extracellular fluid
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K2300/00—Mixtures or combinations of active ingredients, wherein at least one active ingredient is fully defined in groups A61K31/00 - A61K41/00
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- Medicinal Chemistry (AREA)
- Chemical & Material Sciences (AREA)
- General Health & Medical Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Pharmacology & Pharmacy (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Engineering & Computer Science (AREA)
- Epidemiology (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Immunology (AREA)
- Gastroenterology & Hepatology (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Organic Chemistry (AREA)
- General Chemical & Material Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Zoology (AREA)
- Urology & Nephrology (AREA)
- Hematology (AREA)
- Oncology (AREA)
- Dermatology (AREA)
- Diabetes (AREA)
- Pulmonology (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
- Magnetic Resonance Imaging Apparatus (AREA)
- Electrophonic Musical Instruments (AREA)
- Luminescent Compositions (AREA)
- Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
- Medicines Containing Plant Substances (AREA)
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US81360606P | 2006-02-28 | 2006-02-28 | |
PCT/US2007/062936 WO2007101235A2 (en) | 2006-02-28 | 2007-02-28 | Improved antitumoral treatments |
Publications (2)
Publication Number | Publication Date |
---|---|
IL193094A0 IL193094A0 (en) | 2011-08-01 |
IL193094A true IL193094A (en) | 2015-06-30 |
Family
ID=38459806
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
IL193094A IL193094A (en) | 2006-02-28 | 2008-07-28 | Appalidine and other drugs used in the manufacture of a cancer treatment drug when the combination of the two gives a synergistic result |
Country Status (24)
Country | Link |
---|---|
US (1) | US8258098B2 (pt) |
EP (1) | EP2029155B1 (pt) |
JP (2) | JP5393159B2 (pt) |
KR (2) | KR101512503B1 (pt) |
CN (1) | CN101389347B (pt) |
AU (1) | AU2007220050B2 (pt) |
CA (1) | CA2643238C (pt) |
CY (1) | CY1117722T1 (pt) |
DK (1) | DK2029155T3 (pt) |
ES (1) | ES2575518T3 (pt) |
HK (1) | HK1127294A1 (pt) |
HR (1) | HRP20160646T1 (pt) |
HU (1) | HUE028055T2 (pt) |
IL (1) | IL193094A (pt) |
ME (1) | ME02450B (pt) |
MX (1) | MX2008010999A (pt) |
NO (1) | NO342012B1 (pt) |
NZ (1) | NZ571043A (pt) |
PL (1) | PL2029155T3 (pt) |
PT (1) | PT2029155E (pt) |
RS (1) | RS54928B1 (pt) |
RU (1) | RU2481853C2 (pt) |
SI (1) | SI2029155T1 (pt) |
WO (1) | WO2007101235A2 (pt) |
Families Citing this family (15)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
MXPA02004862A (es) * | 1999-11-15 | 2003-01-28 | Pharma Mar Sa | Tratamiento de aplidina para canceres. |
ME02450B (me) | 2006-02-28 | 2016-09-20 | Pharma Mar Sa | POBOLJŠANO LIJEČENJE MULTlPLOG MIJELOMA |
WO2008135793A1 (en) * | 2007-05-04 | 2008-11-13 | Pharma Mar S.A. | Combination of aplidine and carboplatin in anticancer treatments |
US20100240595A1 (en) * | 2007-10-19 | 2010-09-23 | Pharma Mar ,S.A. | Improved Antitumoral Treatments |
RU2010140890A (ru) * | 2008-03-07 | 2012-04-20 | Фарма Мар, С.А. (Es) | Улучшенные способы противоопухолевого лечения |
CN101965191A (zh) * | 2008-03-07 | 2011-02-02 | 法马马有限公司 | 改善的抗癌治疗 |
CA2786266A1 (en) | 2010-01-05 | 2011-07-14 | Celgene Corporation | A combination of an immunomodulatory compound and an artemisinin or a derivative thereof for treating cancer |
BR122017028570B1 (pt) * | 2010-11-12 | 2022-03-03 | Pharma Mar, S.A | Uso de pm01183, ou um sal farmaceuticamente aceitável do mesmo, em combinação sinérgica com um inibidor da topoisomerase i e/ou ii e kit |
JP6116482B2 (ja) * | 2010-12-01 | 2017-04-19 | ニーキ ファーマ インコーポレイテッド | ガリウム錯体を用いる併用療法 |
ES2705001T3 (es) * | 2011-11-09 | 2019-03-21 | Bristol Myers Squibb Co | Tratamiento de neoplasias hematológicas con un anticuerpo anti-CXCR4 |
KR101369936B1 (ko) * | 2011-12-28 | 2014-03-06 | 연세대학교 산학협력단 | 탈리도마이드를 포함하는 루프스 신염 치료용 약학 조성물 |
RU2547999C1 (ru) * | 2013-10-28 | 2015-04-10 | Государственное бюджетное учреждение здравоохранения Московской области "Московский областной научно-исследовательский клинический институт им. М.Ф. Владимирского" (ГБУЗ МО МОНИКИ им. М.Ф. Владимирского) | Способ лечения аденогенного местно-распространенного рака нижнеампулярного отдела прямой кишки |
JOP20190254A1 (ar) | 2017-04-27 | 2019-10-27 | Pharma Mar Sa | مركبات مضادة للأورام |
US20220026432A1 (en) * | 2018-12-14 | 2022-01-27 | Konica Minolta, Inc. | Method for forecasting arrival of drug inside diseased tissue |
CN113018415B (zh) * | 2021-03-17 | 2022-07-01 | 遵义医科大学 | 一种药物组合及其应用 |
Family Cites Families (38)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US4493796A (en) | 1980-09-12 | 1985-01-15 | Board Of Trustees, Univ. Of Ill. | Didemnins A, B, C, and derivatives thereof, as antiviral agents |
US4950649A (en) | 1980-09-12 | 1990-08-21 | University Of Illinois | Didemnins and nordidemnins |
IT1153974B (it) | 1982-09-23 | 1987-01-21 | Erba Farmitalia | Composizioni farmacologiche a base di cisplatino e metodo per il loro ottenimento |
DE3684868D1 (de) | 1985-09-20 | 1992-05-21 | Cernitin Sa | Verwendung von pflanzenpollenextrakten zur herstellung von das wachstum von tumorzellen hemmenden pharmazeutischen praeparaten und verfahren zu ihrer herstellung. |
US4948791A (en) | 1989-04-10 | 1990-08-14 | The Board Of Trustees Of The University Of Illinois | Novel Cytotoxic cyclic depsipeptides from the tunicate trididemnum solidum |
GB8922026D0 (en) | 1989-09-29 | 1989-11-15 | Pharma Mar Sa | Novel anti-viral and cytotoxic agent |
US20030148933A1 (en) | 1990-10-01 | 2003-08-07 | Pharma Mar S.A. | Derivatives of dehydrodidemnin B |
DE4120327A1 (de) | 1991-06-20 | 1992-12-24 | Basf Ag | Neue peptide, ihre herstellung und verwendung |
US5580871A (en) | 1992-11-20 | 1996-12-03 | The Dupont Merck Pharmaceutical Company | 4-Heteroaryl- 1,4-dihydropyridine compounds with calcium agonist and alpha1 -antagonist activity |
US5462726A (en) | 1993-12-17 | 1995-10-31 | Bristol-Myers Squibb Company | Method of inhibiting side effects of solvents containing ricinoleic acid or castor oil or derivatives thereof employing a thromboxane A2 receptor antagonist and pharmaceutical compositions containing such solvents |
US6156724A (en) | 1996-06-07 | 2000-12-05 | Rinehart; Kenneth L. | Uses of didemnins as immunomodulating agents |
DE69723728T2 (de) | 1996-10-24 | 2004-06-03 | The Board Of Trustees For The University Of Illinois, Urbana | Totalsynthese des amino hip analogen von didemnin a |
DE69735583T2 (de) | 1996-10-24 | 2007-04-05 | The Board Of Trustees Of The University Of Illinois, Urbana | Semisynthetisches verfahren zur herstellung von didemninanalogen |
US6034058A (en) | 1997-04-15 | 2000-03-07 | Rinehart; Kenneth L. | Semi-synthetic alanyl dilemnin analogs |
CA2288639A1 (en) | 1997-05-07 | 1998-11-12 | Pharma Mar, S.A. | Aplidine as an l-type calcium channel enhancer |
GB9803448D0 (en) | 1998-02-18 | 1998-04-15 | Pharma Mar Sa | Pharmaceutical formulation |
GB9821975D0 (en) | 1998-10-08 | 1998-12-02 | Pharma Mar Sa | New cytotoxic alkaloids |
US6245759B1 (en) | 1999-03-11 | 2001-06-12 | Merck & Co., Inc. | Tyrosine kinase inhibitors |
RU2266734C2 (ru) * | 1999-05-13 | 2005-12-27 | Фарма Мар, С.А. | Композиции и применение ет743 для лечения злокачественных опухолей |
US6635677B2 (en) * | 1999-08-13 | 2003-10-21 | Case Western Reserve University | Methoxyamine combinations in the treatment of cancer |
MXPA02004862A (es) * | 1999-11-15 | 2003-01-28 | Pharma Mar Sa | Tratamiento de aplidina para canceres. |
US6509315B1 (en) | 2000-04-07 | 2003-01-21 | The Trustees Of The University Of Pennsylvania | Didemnin analogs and fragments and methods of making and using them |
JP2003535048A (ja) | 2000-04-07 | 2003-11-25 | ザ・トラステイーズ・オブ・ザ・ユニバーシテイ・オブ・ペンシルベニア | タマンダリンおよびジデムニン同族体およびそれらの作成および使用法 |
UA76718C2 (uk) | 2000-06-30 | 2006-09-15 | Фарма Мар, С.А. | Протипухлинні похідні аплідину |
JP2004510824A (ja) * | 2000-10-12 | 2004-04-08 | ファルマ・マール・ソシエダード・アノニマ | ガンの治療 |
RU2003113210A (ru) * | 2000-10-12 | 2004-11-27 | Фарма Мар, С.А. (Es) | Лечение раковых заболеваний |
EP1353659A1 (de) | 2001-01-24 | 2003-10-22 | Mestex AG | Verwendung von neurotoxischen substanzen für die herstellung eines mittels zur behandlung von gelenkschmerzen |
ATE411036T1 (de) | 2001-10-19 | 2008-10-15 | Pharma Mar Sa | Verwendung von aplidine in der behandlung von pankreaskrebs |
CN101579520A (zh) | 2003-03-12 | 2009-11-18 | 达纳-法伯癌症协会有限公司 | 用于多发性骨髓瘤的治疗的aplidine |
SI1603584T1 (sl) | 2003-03-12 | 2009-02-28 | Dana Farber Cancer Inst Inc | Aplidin za zdravljenje multiple mieloma |
EP1613338A4 (en) | 2003-03-21 | 2009-06-24 | Madeleine M Joullie | TAMANDARIN ANALOGUES, FRAGMENTS THEREOF AND METHODS OF MAKING AND USING THE SAME |
US20060019256A1 (en) * | 2003-06-09 | 2006-01-26 | The Regents Of The University Of Michigan | Compositions and methods for treating and diagnosing cancer |
ME02450B (me) | 2006-02-28 | 2016-09-20 | Pharma Mar Sa | POBOLJŠANO LIJEČENJE MULTlPLOG MIJELOMA |
DE102006061344A1 (de) * | 2006-12-22 | 2008-06-26 | Robert Bosch Gmbh | Kupplungshydraulikkreis |
WO2008080956A1 (en) | 2006-12-29 | 2008-07-10 | Pharma Mar, S.A. | Prognostic molecular markers for the cancer therapy with aplidine |
WO2008135793A1 (en) | 2007-05-04 | 2008-11-13 | Pharma Mar S.A. | Combination of aplidine and carboplatin in anticancer treatments |
US20100240595A1 (en) | 2007-10-19 | 2010-09-23 | Pharma Mar ,S.A. | Improved Antitumoral Treatments |
WO2010029158A1 (en) | 2008-09-12 | 2010-03-18 | Pharma Mar, S.A. | Aplidine in the treatment of chronic myeloproliferative disorders |
-
2007
- 2007-02-28 ME MEP-2016-115A patent/ME02450B/me unknown
- 2007-02-28 DK DK07757603.1T patent/DK2029155T3/en active
- 2007-02-28 AU AU2007220050A patent/AU2007220050B2/en active Active
- 2007-02-28 ES ES07757603.1T patent/ES2575518T3/es active Active
- 2007-02-28 CA CA2643238A patent/CA2643238C/en active Active
- 2007-02-28 RS RS20160545A patent/RS54928B1/sr unknown
- 2007-02-28 US US12/278,559 patent/US8258098B2/en active Active
- 2007-02-28 EP EP07757603.1A patent/EP2029155B1/en active Active
- 2007-02-28 HU HUE07757603A patent/HUE028055T2/en unknown
- 2007-02-28 SI SI200731777A patent/SI2029155T1/sl unknown
- 2007-02-28 JP JP2008557477A patent/JP5393159B2/ja active Active
- 2007-02-28 MX MX2008010999A patent/MX2008010999A/es active IP Right Grant
- 2007-02-28 NZ NZ571043A patent/NZ571043A/en unknown
- 2007-02-28 WO PCT/US2007/062936 patent/WO2007101235A2/en active Application Filing
- 2007-02-28 PT PT07757603T patent/PT2029155E/pt unknown
- 2007-02-28 KR KR1020087023662A patent/KR101512503B1/ko active IP Right Grant
- 2007-02-28 CN CN2007800068661A patent/CN101389347B/zh active Active
- 2007-02-28 RU RU2008138560/15A patent/RU2481853C2/ru active
- 2007-02-28 PL PL07757603.1T patent/PL2029155T3/pl unknown
- 2007-02-28 KR KR1020147021341A patent/KR20140101014A/ko not_active Application Discontinuation
-
2008
- 2008-07-28 IL IL193094A patent/IL193094A/en active IP Right Grant
- 2008-09-23 NO NO20084047A patent/NO342012B1/no unknown
-
2009
- 2009-07-16 HK HK09106467.2A patent/HK1127294A1/zh unknown
-
2013
- 2013-07-10 JP JP2013144436A patent/JP2013199500A/ja active Pending
-
2016
- 2016-06-10 HR HRP20160646TT patent/HRP20160646T1/hr unknown
- 2016-07-05 CY CY20161100620T patent/CY1117722T1/el unknown
Also Published As
Similar Documents
Publication | Publication Date | Title |
---|---|---|
IL193094A (en) | Appalidine and other drugs used in the manufacture of a cancer treatment drug when the combination of the two gives a synergistic result | |
IL249165A0 (en) | Use of an antigen-mhc complex to prepare drugs for the prevention and treatment of autoimmune conditions | |
EP1985302A4 (en) | DRUGS FOR TUMOR THERAPY AND ITS USE | |
IL200278A (en) | Use of aclidinium for the manufacture of a drug for use in the treatment or prevention of respiratory illness and pharmacist's preparation for the treatment or prevention of respiratory illness | |
EP2142244A4 (en) | MEDICAL DEVICE FOR ADMINISTERING MEDICINE AND / OR PERFORMING PHYSICAL THERAPY | |
PL2601962T3 (pl) | Schemat dawkowania LAG-3 do stosowania w leczeniu raka | |
IL236426B (en) | Use of a compound in combination with bortezomib to prepare a drug for a neoplastic disease and a pharmaceutical preparation containing a compound and bortezomib | |
IL210589A (en) | C2386RV Protein Tuberculosis Kvfb Protein Use for the Treatment or Prevention of TB | |
EP2213318A4 (en) | DRUG SOLUTION DELIVERY SYSTEM AND DRUG SOLUTION ADMINISTRATION CANNULA | |
WO2007146426A3 (en) | Nanoshells for drug delivery | |
IL180565A0 (en) | An improved stopcock for administering medicaments into the patient's body | |
IL193727A0 (en) | Dosage forms for administering combinations of drugs | |
EP1978892A4 (en) | DEVICE FOR TREATING DRUG DELIVERY | |
HK1129594A1 (en) | Use of substituted 2-aminotetralines for the manufacture of a medicament for the prevention, alleviation and/or treatment of various types of pain | |
IL206296A (en) | History of aminopyrazole, and their medicinal products and their use in the preparation of drugs for the prevention and treatment of diseases | |
EP2099449A4 (en) | PHARMACEUTICAL COMPOSITION FOR THE TREATMENT AND PREVENTION OF DISEASES THAT COME WITH IMPOTENCE | |
IL211678A (en) | Use of a refined inhibitor and a pi3 kinase inhibitor in the preparation of a combination drug for cancer treatment or tumor-associated degeneration | |
IL190284A (en) | Use of milenzipran, or a suitable pharmaceutical salt, in the preparation of a drug for the treatment of fibromyalgia | |
ZA200900423B (en) | Methods and medicaments for administration of ibuprofen | |
IL206080A0 (en) | Pharmaceutical composition for use in the treatment and/or the prevention of osteoarticular diseases | |
HK1137352A1 (en) | Therapeutic use of at least one botulic neurotoxin in the treatment of pain induced by at least one antineoplastic agent | |
ZA200905703B (en) | Specific therapy and medicament using integrin ligands for treating cancer | |
GB0722996D0 (en) | Depsipeptides and their therapeutic use | |
HK1132263A1 (en) | Dihydropyrimidine compounds and their uses in manufactures of pharmaceutical medicaments for treatment and prevention against virosis | |
EP2123266A4 (en) | THERAPEUTIC AGENT AGAINST CANCER AND ANTI-CARCINOGENIC AGENT |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
FF | Patent granted | ||
KB | Patent renewed | ||
KB | Patent renewed | ||
KB | Patent renewed |